We are live on
!
Find out more
PA
Profund Advisors Portfolio holdings
AUM
$2.72B
1-Year Est. Return
47.27%
This Fund
S&P 500
This Quarter
Est. Return
+12.51%
1 Year Est. Return
+47.27%
3 Year Est. Return
+155.16%
5 Year Est. Return
+217.35%
10 Year Est. Return
+932.28%
AUM
$1.86B
AUM Growth
+$246M
(+15%)
Cap. Flow
+$82.5M
Cap. Flow
% of AUM
4.43%
Top 10 Holdings %
Top 10 Hldgs %
34.22%
Holding
1,158
New
69
Increased
498
Reduced
498
Closed
91
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$12.9M |
| 2 |
Microsoft
MSFT
|
+$12.5M |
| 3 |
NVIDIA
NVDA
|
+$7.63M |
| 4 |
Amazon
AMZN
|
+$5.14M |
| 5 |
Tesla
TSLA
|
+$4.94M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FISV
Fiserv Inc
FISV
|
+$3.11M |
| 2 |
ExxonMobil
XOM
|
+$2.53M |
| 3 |
IMGN
Immunogen Inc
IMGN
|
+$2.22M |
| 4 |
Chevron
CVX
|
+$2.06M |
| 5 |
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
|
+$1.23M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.9% |
| 2 | Healthcare | 15.37% |
| 3 | Consumer Discretionary | 12.43% |
| 4 | Communication Services | 8.94% |
| 5 | Energy | 5.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
751
Bank OZK
OZK
$5.49B
| $288K | 0.02% |
7,164
-2,398
| -25% | -$86K |
|
752
Churchill Downs
CHDN
$6.03B
| $288K | 0.02% |
2,067
-189
| -8% | -$25.9K |
|
753
Glacier Bancorp
GBCI
$6.55B
| $288K | 0.02% |
9,225
+468
| +5% | +$15.4K |
|
754
Telkom Indonesia
TLK
$14.2B
| $287K | 0.02% |
10,744
+1,725
| +19% | +$47.9K |
|
755
Ventas
VTR
$48.9B
| $286K | 0.02% |
6,048
-117
| -2% | -$5.3K |
|
756
State Street
STT
$50.9B
| $285K | 0.02% |
3,900
-241
| -6% | -$17.3K |
|
757
Casey's General Stores
CASY
$31.9B
| $285K | 0.02% |
1,170
-110
| -9% | -$24.9K |
|
|
SNV
758
DELISTED
Synovus
SNV
| $285K | 0.02% |
9,428
-1,712
| -15% | -$50.1K |
|
759
GDS Holdings
GDS
$6.34B
| $285K | 0.02% |
25,944
-3,713
| -13% | -$49.3K |
|
760
First Financial Bankshares
FFIN
$4.97B
| $285K | 0.02% |
10,003
+99
| +1% | +$2.81K |
|
761
Zebra Technologies
ZBRA
$12.4B
| $284K | 0.02% |
960
+252
| +36% | +$70.7K |
|
762
Merit Medical Systems
MMSI
$4.43B
| $283K | 0.02% |
3,386
+46
| +1% | +$3.74K |
|
763
Hancock Whitney
HWC
$6.13B
| $281K | 0.02% |
7,324
-643
| -8% | -$23.9K |
|
764
Vanda Pharmaceuticals
VNDA
$312M
| $281K | 0.02% |
42,644
-3,041
| -7% | -$19.5K |
|
765
Saia
SAIA
$11.3B
| $280K | 0.02% |
818
-626
| -43% | -$181K |
|
766
Fabrinet
FN
$17.1B
| $280K | 0.02% |
2,155
-11
| -0.5% | -$1.18K |
|
767
Molina Healthcare
MOH
$10.3B
| $280K | 0.02% |
929
+22
| +2% | +$6.32K |
|
|
ALLK
768
DELISTED
Allakos
ALLK
| $279K | 0.02% |
64,054
-4,619
| -7% | -$20.8K |
|
769
Option Care Health
OPCH
$3.4B
| $279K | 0.01% |
8,577
-413
| -5% | -$12.5K |
|
770
Amkor Technology
AMKR
$16.1B
| $278K | 0.01% |
9,355
+317
| +4% | +$7.71K |
|
771
Reinsurance Group of America
RGA
$15.7B
| $278K | 0.01% |
2,006
-388
| -16% | -$55.2K |
|
772
KBR
KBR
$4.68B
| $277K | 0.01% |
4,259
-449
| -10% | -$26.8K |
|
773
Eastman Chemical
EMN
$7.8B
| $277K | 0.01% |
3,304
+176
| +6% | +$14.3K |
|
774
Caesars Entertainment
CZR
$6.1B
| $276K | 0.01% |
+5,416
| New | +$246K |
|
775
Emcor
EME
$33.1B
| $276K | 0.01% |
1,492
-1,060
| -42% | -$177K |
|
Similar funds
MASUI
XL
MSL
CA
TAM
NCM
GC
FNF
Profund Advisors's Q2 2023 Portfolio in Review
As of Q2 2023, Profund Advisors held 1,158 positions worth $1.86B, up 15% from $1.62B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Profund Advisors deployed $82.5M of net new capital in Q2 2023, opening 69 new positions and adding to 498 existing holdings. Its largest new stake was Biomea Fusion: 24,713 shares worth $542K.
By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 33% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Fiserv Inc, an estimated $3.11M trimmed.
- Profund Advisors's largest Q2 2023 buy was Biomea Fusion: 24,713 shares worth $542K.
- Profund Advisors added most to Apple in Q2 2023, an estimated $12.9M increase.
- Profund Advisors's biggest Q2 2023 reduction was Fiserv Inc, cutting an estimated $3.11M.
- Profund Advisors fully exited Prometheus Biosciences, Inc. Common Stock in Q2 2023, selling an estimated $1.23M.
- Profund Advisors's ten largest holdings make up 34% of its $1.86B portfolio in Q2 2023.
- Profund Advisors opened 69 new positions and closed 91 in Q2 2023.
- Profund Advisors's portfolio value rose 15% quarter-over-quarter to $1.86B.
Based on Profund Advisors's 13F filing for Q2 2023, filed 10 Aug 2023.